| Patients (n = 103) | DR2+ (n = 94) | DR2- (n = 9) | Controls (n = 91) |
---|---|---|---|---|
Alleles | Â | Â | Â | Â |
E2 | 8%(16) | 7.5% (14) | 11% (2) | 10%(18) |
E3 | 82%(168) | 83%(155) | 72%(13) | 75%(136) |
E4 | 11%(22) | 10%(19) | 17%(3) | 15%(28) |
Genotypes | Â | Â | Â | Â |
E2/E3 | 14%(14) | 14%(13) | 11%(1) | 18%(16) |
E2/E4 | 2%(2) | 1%(1) | 11%(1) | 2%(2) |
E3/E3 | 66%(68) | 67%(63) | 56%(5) | 55%(50) |
E3/E4 | 18%(18) | 17%(16) | 22%(2) | 22%(20) |
E4/E4 | 1%(1) | 1%(1) | / | 3%(3) |